Alvarado, Israel

Alvarado, Israel was paid $371K by Medicaid between Jan 2018 and Jan 2019, across 27 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	8,057	$370K
2019	13	$1K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	32%	1,475	1,347	$120K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	24%	1,561	1,415	$90K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	11%	947	866	$40K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	8.9%	245	240	$33K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	5.2%	211	204	$19K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	4.7%	175	172	$17K
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	4.4%	280	270	$16K
93000		1.8%	532	516	$7K
94010		1.6%	220	217	$6K
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	1.6%	291	281	$6K
G0444	Annual depression screening, 5 to 15 minutes	1.1%	383	370	$4K
93923		<1%	31	31	$3K

15 more codes

G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	18	$3K
G0442	Annual alcohol misuse screening, 5 to 15 minutes	<1%	129	$1K
81025		<1%	161	$870.15
71046	Radiologic examination, chest; 2 views	<1%	29	$811.53
81002		<1%	392	$797.51
72100		<1%	16	$552.40
82948		<1%	193	$513.28
71045	Radiologic examination, chest; single view	<1%	19	$344.73
99058		<1%	22	$276.59
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	19	$162.71
G8753	Most recent systolic blood pressure >= 140 mmhg	0%	75	$0.00
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	0%	482	$0.00
G8752	Most recent systolic blood pressure < 140 mmhg	0%	28	$0.00
G8755	Most recent diastolic blood pressure >= 90 mmhg	0%	118	$0.00
G8754	Most recent diastolic blood pressure < 90 mmhg	0%	18	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.